© 1999 American Heart Association, Inc.
Original Contributions |
Omega-3 Fatty Acids in Adipose Tissue and Risk of Myocardial Infarction
The EURAMIC Study
From the Department of Epidemiology and Biostatistics, National School of Public Health, "Instituto de Salud Carlos III" (E.G., J.M.M.-M.), Madrid, Spain; Department of Nutrition, National Public Health Institute (A.A., I.S., J.K.H.), Helsinki, Finland; Research Unit, "Fundación Jiménez Díaz" (F.J.J.), Madrid, Spain; Division of Human Nutrition and Epidemiology, Wageningen Agricultural University (P.V.V., F.J.K.), Wageningen, The Netherlands; Department of Consumer Research and Epidemiology, TNO Nutrition and Food Research Institute (A.F.M.K.), Zeist, The Netherlands; Department of Preventive Medicine and Public Health, University of Málaga (J.G.-A.), Málaga, Spain; Institute of Social and Preventive Medicine, Zürich University (B.C.M.), Zürich, Switzerland; University of North Carolina (L.K.), Chapel Hill; Epidemiology Unit, Hadassah Medical Organization and Hebrew University (J.D.K.), Jerusalem, Israel; Research Center for Preventive Medicine (V.P.M.), Moscow, Russia; Østfold Central Hospital (J.R.), Fredrikstad, Norway; Department of Preventive Medicine and Public Health, University of Granada (J.G.), Granada, Spain; Cardiovascular Research Unit, University of Edinburgh (R.A.R.), Edinburgh, United Kingdom; and Department of Health Risks and Prevention, Robert Koch Institute (M.T.), Berlin, Germany.
Correspondence and reprint requests to Eliseo Guallar, Departamento de Epidemiología y Bioestadística, Escuela Nacional de Sanidad, Instituto de Salud Carlos III. Sinesio Delgado 8, 28029 Madrid, Spain. E-mail eguallar{at}isciii.es
Abstract—Omega-3 fatty acids
have potential antiatherogenic, antithrombotic, and antiarrhythmic
properties, but their role in coronary heart disease remains
controversial. To evaluate the association of omega-3 fatty acids in
adipose tissue with the risk of myocardial infarction in men, a
case-control study was conducted in eight European countries and
Israel. Cases (n=639) included patients with a first myocardial
infarction admitted to coronary care units within 24 hours from
the onset of symptoms. Controls (n=700) were selected to
represent the populations originating the cases. Adipose tissue
levels of fatty acids were determined by capillary gas
chromatography. The mean (±SD) proportion of
-linolenic acid was 0.77% (±0.19) of fatty acids in cases
and 0.80% (±0.19) of fatty acids in controls (P=0.01).
The relative risk for the highest quintile of -linolenic
acid compared with the lowest was 0.42 (95% confidence interval [CI]
0.22 to 0.81, P-trend=0.02). After adjusting for
classical risk factors, the relative risk for the highest quintile was
0.68 (95% CI 0.31 to 1.49, P-trend=0.38). The mean
proportion of docosahexaenoic acid was 0.24% (±0.13) of fatty acids
in cases and 0.25% (±0.13) of fatty acids in controls
(P=0.14), with no evidence of association with risk of
myocardial infarction. In this large case-control study we could not
detect a protective effect of docosahexaenoic acid on the risk of
myocardial infarction. The protective effect of -linolenic
acid was attenuated after adjusting for classical risk factors (mainly
smoking), but it deserves further research.
Key Words: myocardial infarction • -linolenic acid • docosahexaenoic acid • case-control studies • adipose tissue.
This article has been cited by other articles:
 |
|
 |
|
  A. A. Amin, R. A. Menon, K. J. Reid, W. S. Harris, and J. A. Spertus Acute Coronary Syndrome Patients With Depression Have Low Blood Cell Membrane Omega-3 Fatty Acid Levels Psychosom Med, October 1, 2008; 70(8): 856 - 862. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. J. Jung, C. Torrejon, A. P Tighe, and R. J Deckelbaum n-3 Fatty acids and cardiovascular disease: mechanisms underlying beneficial effects Am. J. Clinical Nutrition, June 1, 2008; 87(6): 2003S - 2009S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Baylin, E. Ruiz-Narvaez, P. Kraft, and H. Campos {alpha}-Linolenic acid, {Delta}6-desaturase gene polymorphism, and the risk of nonfatal myocardial infarction Am. J. Clinical Nutrition, February 1, 2007; 85(2): 554 - 560. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Lee, K. M. Gura, S. Kim, D. A. Arsenault, B. R. Bistrian, and M. Puder Current Clinical Applications of {Omega}-6 and {Omega}-3 Fatty Acids Nutr Clin Pract, August 1, 2006; 21(4): 323 - 341. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. P. Zaloga, N. Ruzmetov, K. A. Harvey, C. Terry, N. Patel, W. Stillwell, and R. Siddiqui (n-3) Long-Chain Polyunsaturated Fatty Acids Prolong Survival following Myocardial Infarction in Rats J. Nutr., July 1, 2006; 136(7): 1874 - 1878. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D Kark, R. Fink, B. Adler, N. Goldberger, and S. Goldman The incidence of coronary heart disease among Palestinians and Israelis in Jerusalem Int. J. Epidemiol., April 1, 2006; 35(2): 448 - 457. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H.K. Vogel, S. F. Bolling, R. B. Costello, E. M. Guarneri, M. W. Krucoff, J. C. Longhurst, B. Olshansky, K. R. Pelletier, C. M. Tracy, R. A. Vogel, et al. Integrating Complementary Medicine Into Cardiovascular Medicine: A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (Writing Committee to Develop an Expert Consensus Document on Complementary and Integrative Medicine) J. Am. Coll. Cardiol., July 5, 2005; 46(1): 184 - 221. [Full Text] [PDF]
|
|
|
|
 |
|
 N. Hussein, E. Ah-Sing, P. Wilkinson, C. Leach, B. A. Griffin, and D. J. Millward Long-chain conversion of [13C]linoleic acid and {alpha}-linolenic acid in response to marked changes in their dietary intake in men J. Lipid Res., February 1, 2005; 46(2): 269 - 280. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Tavani, S. Gallus, C. La Vecchia, A. Baylin, E. K. Kabagambe, A. Ascherio, D. Spiegelman, and H. Campos {alpha}-Linolenic Acid and Nonfatal Acute Myocardial Infarction * Response Circulation, October 28, 2003; 108 (17): e127 - e128. [Full Text] [PDF]
|
|
|
|
|
|
S. Rajaram The effect of vegetarian diet, plant foods, and phytochemicals on hemostasis and thrombosis Am. J. Clinical Nutrition, September 1, 2003; 78(3): 552S - 558. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. C Davis and P. M Kris-Etherton Achieving optimal essential fatty acid status in vegetarians: current knowledge and practical implications Am. J. Clinical Nutrition, September 1, 2003; 78(3): 640S - 646. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. T Erkkila, S. Lehto, K. Pyorala, and M. I. Uusitupa n-3 Fatty acids and 5-y risks of death and cardiovascular disease events in patients with coronary artery disease Am. J. Clinical Nutrition, July 1, 2003; 78(1): 65 - 71. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D Kark, N. A Kaufmann, F. Binka, N. Goldberger, and E. M Berry Adipose tissue n-6 fatty acids and acute myocardial infarction in a population consuming a diet high in polyunsaturated fatty acids Am. J. Clinical Nutrition, April 1, 2003; 77(4): 796 - 802. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Baylin, E. K. Kabagambe, A. Ascherio, D. Spiegelman, and H. Campos Adipose Tissue {alpha}-Linolenic Acid and Nonfatal Acute Myocardial Infarction in Costa Rica Circulation, April 1, 2003; 107(12): 1586 - 1591. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. M. Kris-Etherton, W. S. Harris, L. J. Appel, and for the Nutrition Committee Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease Arterioscler Thromb Vasc Biol, February 1, 2003; 23(2): e20 - 30. [Full Text] [PDF]
|
|
|
|
 |
|
 E. Guallar, M. I. Sanz-Gallardo, P. v.'t Veer, P. Bode, A. Aro, J. Gomez-Aracena, J. D. Kark, R. A. Riemersma, J. M. Martin-Moreno, F. J. Kok, et al. Mercury, Fish Oils, and the Risk of Myocardial Infarction N. Engl. J. Med., November 28, 2002; 347(22): 1747 - 1754. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M. Kris-Etherton, W. S. Harris, L. J. Appel, and for the Nutrition Committee Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease Circulation, November 19, 2002; 106(21): 2747 - 2757. [Full Text] [PDF]
|
|
|
|
|
|
E. B. Feldman The Scientific Evidence for a Beneficial Health Relationship Between Walnuts and Coronary Heart Disease J. Nutr., May 1, 2002; 132(5): 1062S - 1101. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M Oomen, M. C Ocke, E. J. Feskens, F. J Kok, and D. Kromhout {alpha}-Linolenic acid intake is not beneficially associated with 10-y risk of coronary artery disease incidence: the Zutphen Elderly Study Am. J. Clinical Nutrition, October 1, 2001; 74(4): 457 - 463. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Marchioli Treatment with n-3 polyunsaturated fatty acids after myocardial infarction: results of GISSI-prevenzione trial Eur. Heart J. Suppl., June 1, 2001; 3(suppl_D): D85 - D97. [Abstract] [PDF]
|
|
|
|
|
|
R. M. Krauss, R. H. Eckel, B. Howard, L. J. Appel, S. R. Daniels, R. J. Deckelbaum, J. W. Erdman Jr, P. Kris-Etherton, I. J. Goldberg, T. A. Kotchen, et al. AHA Scientific Statement: AHA Dietary Guidelines: Revision 2000: A Statement for Healthcare Professionals From the Nutrition Committee of the American Heart Association J. Nutr., January 1, 2001; 131(1): 132 - 146. [Full Text]
|
|
|
|
|
|
T. Rissanen, S. Voutilainen, K. Nyyssonen, T. A. Lakka, and J. T. Salonen Fish Oil-Derived Fatty Acids, Docosahexaenoic Acid and Docosapentaenoic Acid, and the Risk of Acute Coronary Events : The Kuopio Ischaemic Heart Disease Risk Factor Study Circulation, November 28, 2000; 102(22): 2677 - 2679. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Krauss, R. H. Eckel, B. Howard, L. J. Appel, S. R. Daniels, R. J. Deckelbaum, J. W. Erdman Jr, P. Kris-Etherton, I. J. Goldberg, T. A. Kotchen, et al. AHA Dietary Guidelines : Revision 2000: A Statement for Healthcare Professionals From the Nutrition Committee of the American Heart Association Stroke, November 1, 2000; 31(11): 2751 - 2766. [Full Text] [PDF]
|
|
|
|
|
|
R. M. Krauss, R. H. Eckel, B. Howard, L. J. Appel, S. R. Daniels, R. J. Deckelbaum, J. W. Erdman Jr, P. Kris-Etherton, I. J. Goldberg, T. A. Kotchen, et al. AHA Dietary Guidelines : Revision 2000: A Statement for Healthcare Professionals From the Nutrition Committee of the American Heart Association Circulation, October 31, 2000; 102(18): 2284 - 2299. [Full Text] [PDF]
|
|